July 6, 2022
RFA-HL-23-015 - New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI): Clinical/Community Field Centers (UG3/UH3 - Clinical Trial Not Allowed)
RFA-HL-23-016 - New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI): Coordinating Center (U24 - Clinical Trial Not Allowed)
NOT-HL-22-034 - Notice of Technical Assistance Webinar for NHLBI New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI) Clinical/Community Field Centers (UG3/UH3) RFA-HL-23-015 and Coordinating Center (U24) RFA-HL-23-01
National Heart, Lung, and Blood Institute (NHLBI)
The purpose of this Notice is to inform potential applicants that NHLBI has posted a set of responses to Frequently Asked Questions (FAQs) regarding RFA-HL-23-015 (New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI): Clinical/Community Field Centers (UG3/UH3) and RFA-HL-23-016: New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI): Coordinating Center (U24)."
The FAQs are available on the NHLBI website at the following link: https://www.nhlbi.nih.gov/node-general/frequently-asked-questions-new-epidemiological-cohort-study-among-asian-americans
Applicants are strongly encouraged to review the FAQs, which may be updated at any time without additional notice, prior to submitting their application.
Scientific/Research Contact(s)
Stephanie Marquez, M.P.H.
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-402-0965
Email: [email protected]
Ye Yan, Ph.D.
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-480-6779
Email: [email protected]